Buy Saxenda (liraglutide) 6mg/ml 3ml pen for sale

$900.00

Buy Saxenda (liraglutide) 6mg/ml 3ml pen for sale. Saxenda (liraglutide) injection 3 mg is an injectable medicine that may help some adults with excess weight (BMI ≥27) who also have weight-related medical problems or obesity (BMI ≥30) lose weight and keep the weight off. Saxenda should be used with a reduced-calorie meal plan and increased physical activity.

Buy Saxenda (liraglutide) 6mg/ml 3ml pen for sale

Email:  [email protected]

Description

Buy Saxenda (liraglutide) 6mg/ml 3ml pen for sale. Saxenda (liraglutide) injection 3 mg is an injectable medicine that may help some adults with excess weight (BMI ≥27) who also have weight-related medical problems or obesity (BMI ≥30) lose weight and keep the weight off. Saxenda should be used with a reduced-calorie meal plan and increased physical activity.

Buy Saxenda (liraglutide) 6mg/ml 3ml pen for sale

Email:  [email protected]

Saxenda contains liraglutide, an analog of human GLP-1 and acts as a GLP-1 receptor agonist. The peptide precursor of liraglutide, produced by a process that includes expression of recombinant DNA in Saccharomyces cerevisiae, has been engineered to be 97% homologous to native human GLP-1 by substituting arginine for lysine at position 34. Liraglutide is made by attaching a C-16 fatty acid (palmitic acid) with a glutamic acid spacer on the remaining lysine residue at position 26 of the peptide precursor.

DOSAGE AND ADMINISTRATION
The recommended dosage of Saxenda is 3 mg daily. If patients do not tolerate an increased dose during dose escalation, consider delaying dose escalation for approximately one additional week. Saxenda should be discontinued, however, if a patient cannot tolerate the 3 mg dose, as efficacy has not been established at lower doses (0.6, 1.2, 1.8, and 2.4 mg).

Saxenda should be taken once daily at any time of day, without regard to the timing of meals. Saxenda can be injected subcutaneously in the abdomen, thigh, or upper arm. The injection site and timing can be changed without dose adjustment. Saxenda must not be administered intravenously or intramuscularly.

When initiating Saxenda in patients taking insulin secretagogues (such as sulfonylureas), consider reducing the dose of the insulin secretagogue (for example, by one-half) to reduce the risk for hypoglycemia, and monitor blood glucose. Saxenda and insulin should not be used together.Conversely, if discontinuing Saxenda in patients with type 2 diabetes, monitor for an increase in blood glucose.

Evaluate the change in body weight 16 weeks after initiating Saxenda and discontinue Saxenda if the patient has not lost at least 4% of baseline body weight, since it is unlikely that the patient will achieve and sustain clinically meaningful weight loss with continued treatment.

If a dose is missed, the once-daily regimen should be resumed as prescribed with the next scheduled dose. An extra dose or increase in dose should not be taken to make up for the missed dose. If more than 3 days have elapsed since the last Saxenda dose, patients should reinitiate Saxenda at 0.6 mg daily and follow the dose escalation schedule in Table 1, which may reduce the occurrence of gastrointestinal symptoms associated with reinitiation of treatment.

Prior to initiation of Saxenda, patients should be trained by their healthcare professional on proper injection technique. Training reduces the risk of administration errors such as needle sticks and incomplete dosing. Refer to the accompanying Instructions for Use for complete administration instructions with illustrations.

Saxenda solution should be inspected prior to each injection, and the solution should be used only if it is clear, colorless, and contains no particles.

 

Buy Saxenda (liraglutide) 6mg/ml 3ml pen for sale

Limitations Of Use
Saxenda is not indicated for the treatment of type 2 diabetes mellitus.

Saxenda and Victoza both contain the same active ingredient, liraglutide, and therefore should not be used together. Saxenda should not be used in combination with any other GLP-1 receptor agonist.

Saxenda has not been studied in patients taking insulin. Saxenda and insulin should not be used together

The safety and effectiveness of Saxenda in combination with other products intended for weight loss, including prescription drugs, over-the-counter drugs, and herbal preparations, have not been established.

 

Buy Saxenda (liraglutide) 6mg/ml 3ml pen for sale

Who should not use Saxenda?
Do not use Saxenda if:

you or any of your family have a history of MTC

you have MEN 2. This is a disease where people have tumors in more than one gland in their body

you are allergic to liraglutide or any of the ingredients in Saxenda.

Symptoms of a serious allergic reaction may include: swelling of your face, lips, tongue, or throat, fainting or feeling dizzy, very rapid heartbeat, problems breathing or swallowing, and severe rash or itching

Buy Saxenda (liraglutide) 6mg/ml 3ml pen for sale